Biofarmex was founded through the acquisition of a company already present on the market with 142 Marketing authorization (AIC) related to Homeopathic medicines registered with the Ministry of Health.
Biofarmex acquired shares of manufacturing companies regularly authorized by the Ministry of Health, namely Homoeopathic Siffra, based in Piasco (CN), and Siffra Pharmintek, based in Rosolini (SR). Therefore the competitiveness and the reliability in the market were increased through optimized business processes that guarantee the high-quality of our products.
Biofarmex established the new Research and Development department stuffed by internal Scientific Committee, composed of doctors and biologists. Such goal promoted both the study and the formulation of new products oriented towards the novel frontiers of nutrigenomics and pharmacogenomics, in addition to scientific and training conferences in Italy and abroad.
Biofarmex inaugurated the new Diagnostic area.
Biofarmex introduced on the market EXTRAGEM®, meristem-derivatives of excellence and high Italian quality.